Monoclonal antibody expression in mammalian cells

Methods in Molecular Biology

Volumn 907, Issue , 2012, Pages 341-358

  Zhang, Richard Yi ^a   Shen, Wenyan David ^b  

^a Accurus Biosciences Inc   (United States)

^b TEVA PHARMACEUTICALS   (Israel)

Author keywords

293EBNA cells; Cellbag; CHO cells; Monoclonal antibody (mAb); Transient transfection; WAVE bioreactor

Indexed keywords

EID: 84867783904     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-61779-974-7_20     Document Type: Article

References (46)

1. Beck A, Wurch T, Reichert JM (2011) 6th Annual European Antibody Congress 2010: November 29-December 1, 2010, Geneva, Switzerland. MAbs 3:111-132
2. Nelson AL, Dhimolea E, Reichert JM (2010) Development trends for human monoclonal antibody therapeutics. Nat Rev Drug Discov 9:767-774
3. Durocher Y, Butler M (2009) Expression systems for therapeutic glycoprotein production. Curr Opin Biotechnol 20:700-707
4. Jones Susan Dana, Castillo Francisco J, Levine Howard L (2007) Advances in the development of therapeutic monoclonal antibodies. BioPharm Int 96-114
5. Wurm FM (2004) Production of recombinant protein therapeutics in cultivated mammalian cells. Nat Biotechnol 22:1393-1398
6. Havenga MJ, Holterman L, Melis I, Smits S, Kaspers J, Heemskerk E, van der Vlugt R, Koldijk M, Schouten GJ, Hateboer G et al (2008) Serum-free transient protein production system based on adenoviral vector and PER.C6 technology: high yield and preserved bioactivity. Biotechnol Bioeng 100:273-283
7. Barnes LM, Bentley CM, Dickson AJ (2000) Advances in animal cell recombinant protein production: GS-NS0 expression system. Cytotechnology 32:109-123
8. Bebbington CR, Renner G, Thomson S, King D, Abrams D, Yarranton GT (1992) High-level expression of a recombinant antibody from myeloma cells using a glutamine synthetase gene as an ampli fi able selectable marker. Biotechnology (NY) 10:169-175
9. Kaufman RJ, Schimke RT (1981) Ampli fi cation and loss of dihydrofolate reductase genes in a Chinese hamster ovary cell line. Mol Cell Biol 1:1069-1076
10. Urlaub G, Kas E, Carothers AM, Chasin LA (1983) Deletion of the diploid dihydrofolate reductase locus from cultured mammalian cells. Cell 33:405-412
11. Kaufman RJ, Sharp PA (1982) Ampli fi cation and expression of sequences cotransfected with a modular dihydrofolate reductase complementary DNA gene. J Mol Biol 159:601-621
12. Ringold G, Dieckmann B, Lee F (1981) Co-expression and ampli fi cation of dihydrofolate reductase cDNA and the Escherichia coli XGPRT gene in Chinese hamster ovary cells. J Mol Appl Genet 1:165-175
13. Cockett MI, Bebbington CR, Yarranton GT (1990) High level expression of tissue inhibitor of metalloproteinases in Chinese hamster ovary cells using glutamine synthetase gene ampli fi cation. Biotechnology (NY) 8:662-667
14. de la Cruz Edmonds MC, Tellers M, Chan C, Salmon P, Robinson DK, Markusen J (2006) Development of transfection and high-producer screening protocols for the CHOK1SV cell system. Mol Biotechnol 34:179-190
15. Ye J, Alvin K, Latif H, Hsu A, Parikh V, Whitmer T, Tellers M, de la Cruz Edmonds MC, Ly J, Salmon P et al (2010) Rapid protein production using CHO stable transfection pools. Biotechnol Prog 26:1431-1437
16. Andersen DC, Reilly DE (2004) Production technologies for monoclonal antibodies and their fragments. Curr Opin Biotechnol 15:456-462
17. Benton T, Chen T, McEntee M, Fox B, King D, Crombie R, Thomas TC, Bebbington C (2002) The use of UCOE vectors in combination with a preadapted serum free, suspension cell line allows for rapid production of large quantities of protein. Cytotechnology 38:43-46
18. Bianchi AA, McGrew JT (2003) High-level expression of full-length antibodies using transcomplementing expression vectors. Biotechnol Bioeng 84:439-444
19. Kwaks TH, Barnett P, Hemrika W, Siersma T, Sewalt RG, Satijn DP, Brons JF, van Blokland R, Kwakman P, Kruckeberg AL et al (2003) Identi fi cation of anti-repressor elements that confer high and stable protein production in mammalian cells. Nat Biotechnol 21:553-558
20. Zahn-Zabal M, Kobr M, Girod PA, Imhof M, Chatellard P, De JM, Wurm F, Mermod N (2001) Development of stable cell lines for production or regulated expression using matrix attachment regions. J Biotechnol 87:29-42
21. Hacker DL, De JM, Wurm FM (2009) 25 Years of recombinant proteins from reactor-grown cells-where do we go from here? Biotechnol Adv 27:1023-1027
22. Baldi L, Hacker DL, Adam M, Wurm FM (2007) Recombinant protein production by large-scale transient gene expression in mammalian cells: state of the art and future perspectives. Biotechnol Lett 29:677-684
23. Girard P, Derouazi M, Baumgartner G, Bourgeois M, Jordan M, Jacko B, Wurm FM (2002) 100-Liter transient transfection. Cytotechnology 38:15-21
24. Pham PL, Kamen A, Durocher Y (2006) Largescale transfection of mammalian cells for the fast production of recombinant protein. Mol Biotechnol 34:225-237
25. Durocher Y, Perret S, Kamen A (2002) Highlevel and high-throughput recombinant protein production by transient transfection of suspension-growing human 293-EBNA1 cells. Nucleic Acids Res 30:E9
26. Meissner P, Pick H, Kulangara A, Chatellard P, Friedrich K, Wurm FM (2001) Transient gene expression: recombinant protein production with suspension-adapted HEK293-EBNA cells. Biotechnol Bioeng 75:197-203
27. Backliwal G, Hildinger M, Chenuet S, Wulhfard S, De JM, Wurm FM (2008) Rational vector design and multi-pathway modulation of HEK 293E cells yield recombinant antibody titers exceeding 1 g/l by transient transfection under serum-free conditions. Nucleic Acids Res 36:e96
28. Zhang J, Liu X, Bell A, To R, Baral TN, Azizi A, Li J, Cass B, Durocher Y (2009) Transient expression and puri fi cation of chimeric heavy chain antibodies. Protein Exp Purif 65:77-82
29. Backliwal G, Hildinger M, Chenuet S, Dejesus M, Wurm FM (2008) Coexpression of acidic fi broblast growth factor enhances speci fi c productivity and antibody titers in transiently transfected HEK293 cells. Nat Biotechnol 25:162-166
30. Backliwal G, Hildinger M, Kuettel I, Delegrange F, Hacker DL, Wurm FM (2008) Valproic acid: a viable alternative to sodium butyrate for enhancing protein expression in mammalian cell cultures. Biotechnol Bioeng 101:182-189
31. Rajendra Y, Kiseljak D, Baldi L, Hacker DL, Wurm FM (2011) A simple high-yielding process for transient gene expression in CHO cells. J Biotechnol 153:22-26
32. Ye J, Kober V, Tellers M, Naji Z, Salmon P, Markusen JF (2009) High-level protein expression in scalable CHO transient transfection. Biotechnol Bioeng 103:542-551
33. Codamo J, Munro TP, Hughes BS, Song M, Gray PP (2011) Enhanced CHO cell-based transient gene expression with the epi-CHO expression system. Mol Biotechnol 48: 109-115
34. Silla T, Haal I, Geimanen J, Janikson K, Abroi A, Ustav E, Ustav M (2005) Episomal maintenance of plasmids with hybrid origins in mouse cells. J Virol 79:15277-15288
35. Product information and use protocols for FuGENE HD and X-tremeGENE HP DNA transfection reagents. www.roche-appliedscience.com . 2011
36. Singh V (1999) Disposable bioreactor for cell culture using wave-induced agitation. Cytotechnology 30:149-158
37. Werner S, Eibl R, Lettenbauer C, Roll M, Eibl D, De JM, Zhang X, Stettler M, Tissot S, Burki C et al (2010) Innovative, non-stirred bioreactors in scales from milliliters up to 1000 liters for suspension cultures of cells using disposable bags and containers-a Swiss contribution. Chimia (Aarau) 64:819-823
38. Zhang X, Stettler M, De SD, Perrone M, Parolini N, Discacciati M, De JM, Hacker D, Quarteroni A, Wurm F (2010) Use of orbital shaken disposable bioreactors for mammalian cell cultures from the milliliter-scale to the 1,000-liter scale. Adv Biochem Eng Biotechnol 115:33-53
39. Kalmbach A, Bordas R, Oncul AA, Thevenin D, Genzel Y, Reichl U (2011) Experimental characterization of fl ow conditions in 2-and 20-L bioreactors with wave-induced motion. Biotechnol Prog 27:402-409
40. Raymond C, Tom R, Perret S, Moussouami P, L'abbe D, St-Laurent G, Durocher Y (2011) A simpli fi ed polyethylenimine-mediated transfection process for large-scale and high-throughput applications. Methods 55(1):44-51
41. Hami LS, Green C, Leshinsky N, Markham E, Miller K, Craig S (2004) GMP production and testing of Xcellerated T cells for the treatment of patients with CLL. Cytotherapy 6:554-562
42. Franek F, Hohenwarter O, Katinger H (2000) Plant protein hydrolysates: preparation of de fi ned peptide fractions promoting growth and production in animal cells cultures. Biotechnol Prog 16:688-692
43. Franek F, Eckschlager T, Katinger H (2003) Enhancement of monoclonal antibody production by lysine-containing peptides. Biotechnol Prog 19:169-174
44. Wulhfard S, Baldi L, Hacker DL, Wurm F (2010) Valproic acid enhances recombinant mRNA and protein levels in transiently transfected Chinese hamster ovary cells. J Biotechnol 148:128-132
45. Wulhfard S, Tissot S, Bouchet S, Cevey J, De JM, Hacker DL, Wurm FM (2008) Mild hypothermia improves transient gene expression yields several fold in Chinese hamster ovary cells. Biotechnol Prog 24:458-465
46. WAVE Bioreactor Literature. www.gelifesciences.com/aptrix/upp01077.nsf/ Content/wave-bioreactor-homewave-literature.2011